These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3582236)

  • 21. Effect of forphenicinol, a small molecular immunomodifier, in combination with cyclophosphamide on growth of and immunity to syngeneic murine tumors.
    Nitta K; Tanaka T; Takeuchi M
    Cancer Treat Rep; 1985 Mar; 69(3):285-91. PubMed ID: 3978657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peritoneal cell populations during tumour injection.
    De Heer E; De Groot JW; Den Otter W; Dullens HF
    Int J Tissue React; 1982; 4(1):81-90. PubMed ID: 7085002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The activity of natural killer cells in healthy and tumor-bearing mice after treatment with low-intensity laser light].
    Cherenkov DA; Novoselova EG; Glushkova OV; Sinotova OA; Sultanova AN; Chudnovskiĭ AN; Fesenko EE
    Biofizika; 2005; 50(1):114-8. PubMed ID: 15759510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Morphological and biochemical study of the organs of immunogenesis during the growth of established glioblastoma multiforme in albino rat brain].
    Bezuglova TV; Iurkiv VA
    Biull Eksp Biol Med; 1975 Jul; 80(7):84-8. PubMed ID: 179646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HPV16-associated tumours: therapy of surgical minimal residual disease with dendritic cell-based vaccines.
    Reinis M; Indrová M; Mendoza L; Mikysková R; Bieblová J; Bubeník J; Símová J
    Int J Oncol; 2004 Oct; 25(4):1165-70. PubMed ID: 15375569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered host-allograft relationships for mouse tumors modified by prior passage in vitro and in vivo. II. Reactivity of lymphoid cells.
    Jacobs BB
    J Natl Cancer Inst; 1972 Oct; 49(4):1085-91. PubMed ID: 4404346
    [No Abstract]   [Full Text] [Related]  

  • 27. [Kinetics of changes in the weight of lymphoid organs and their cellular composition following transplantation of leukemias with different numbers of cells].
    Epokhin VV; Dronova LM; Belich EI
    Izv Akad Nauk SSSR Biol; 1978; (5):773-7. PubMed ID: 361790
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunoregulatory changes induced by total lymphoid irradiation (TLI). I. Appearance of a population of cells bearing the thymus leukemia (TL) surface antigen in the lymph nodes and spleen.
    King DP; Strober S; Kaplan HS
    J Immunol; 1981 Sep; 127(3):1085-9. PubMed ID: 6973579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [An attempt to control the growth of syngeneic experimental tumors in inbred mice using Listeria factor Ei, BCG vaccine and a combination of both].
    Zák M; Mára M; Jirkovský J
    Sb Lek; 1989 Sep; 91(8):230-7. PubMed ID: 2617123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Administration of subtumor regression dosage of TNF-alpha to mice with pre-existing parental tumors augments the vaccination effect of TNF gene-modified tumor through the induction of MHC class I molecule.
    Lu Y; Yamauchi N; Koshita Y; Fujiwara H; Sato Y; Fujii S; Takahashi M; Sato T; Kato J; Yamagishi H; Niitsu Y
    Gene Ther; 2001 Apr; 8(7):499-507. PubMed ID: 11319616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines.
    Wang J; Saffold S; Cao X; Krauss J; Chen W
    J Immunol; 1998 Nov; 161(10):5516-24. PubMed ID: 9820528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Development of antitumor immunity in animals treated with carminomycin].
    Shapovalova SP; Aleksander SK; Liashenko VA
    Antibiotiki; 1981 Apr; 26(4):302-6. PubMed ID: 7235671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kinetics of recovery of serum Ig levels and of cytoplasmic Ig positive cells in various lymphoid organs of nude mice after thymus transplantation.
    Haaijman JJ; Slingerland-Teunissen J; Van Oudenaren A; Mink JG; Benner R
    Immunology; 1980 Oct; 41(2):279-87. PubMed ID: 7439931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Role of immunologic activity of host in radiotherapy].
    Tsuchiya T
    Gan No Rinsho; 1983 Oct; 29(13):1499-505. PubMed ID: 6608014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absence of Peyer's patches and abnormal lymphoid architecture in chronic proliferative dermatitis (cpdm/cpdm) mice.
    HogenEsch H; Janke S; Boggess D; Sundberg JP
    J Immunol; 1999 Apr; 162(7):3890-6. PubMed ID: 10201907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dendritic cells in antitumor immune responses. II. Dendritic cells grown from bone marrow precursors, but not mature DC from tumor-bearing mice, are effective antigen carriers in the therapy of established tumors.
    Gabrilovich DI; Nadaf S; Corak J; Berzofsky JA; Carbone DP
    Cell Immunol; 1996 May; 170(1):111-9. PubMed ID: 8665591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biodistribution and vaccine efficiency of murine dendritic cells are dependent on the route of administration.
    Eggert AA; Schreurs MW; Boerman OC; Oyen WJ; de Boer AJ; Punt CJ; Figdor CG; Adema GJ
    Cancer Res; 1999 Jul; 59(14):3340-5. PubMed ID: 10416590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of resistance to MOPC-315 plasmacytoma after intralesional and intraperitoneal melphalan therapy of tumor-bearing BALB/c mice. I. Enhancement of in vivo rejection responses by combined chemotherapy-immunotherapy.
    Adler A; Altbaum I
    J Natl Cancer Inst; 1982 Jun; 68(6):963-9. PubMed ID: 6953275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Murine dendritic cells modified with CXCL10 gene and tumour cell lysate mediate potent antitumour immune responses in mice.
    Li B; Li Q; Zhao QL; Wei XB; Zhang XH; Wu CQ; Zhong CP
    Scand J Immunol; 2007 Jan; 65(1):8-13. PubMed ID: 17212761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HPV 16-associated tumours: IL-12 can repair the absence of cytotoxic and proliferative responses of tumour infiltrating cells after chemotherapy.
    Indrová M; Bieblová J; Rossowska J; Kuropka P; Pajtasz-Piasecka E; Bubeník J; Reinis M
    Int J Oncol; 2009 Jan; 34(1):173-9. PubMed ID: 19082488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.